Contact Lifestream



Profiting from ‘mental illness’

As many well know, the American Psychiatric Association publishes a little something called the Diagnostic and Statistical Manual of Mental Disorders, or DSM for short. Now it turns out that the majority of the experts “who wrote the manual widely used to diagnose mental illness have had financial ties to drug makers such as research funding or stock holdings.” Not only does this bring up the issue of overprescription and whether chemical treatments are in fact always the correct way to go about certain conditions. It also raises questions whether the industry and its bought experts could even make up or at the very least exaggerate the severity of conditions in order to fill their coffers and prop up their status.